newratings.com  Sep 16  Comment 
YORK (PENNSYLVANIA) (dpa-AFX) - Following a positive pre-NDA meeting with the FDA, Amicus Therapeutics (FOLD) plans to submit an NDA for its investigational product Migalastat for the treatment of Fabry disease in the fourth quarter of 2015 under...
Benzinga  Sep 15  Comment 
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Vanda's filing of a supplemental New Drug Application (sNDA) for FanaptĀ® seeking approval as a maintenance...
Benzinga  Sep 10  Comment 
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a favorable Markman ruling has been issued by the United States District Court for the District of Delaware in the patent infringement lawsuit filed by Vanda against Roxane...
Motley Fool  Jul 30  Comment 
Sequential growth for Vanda Pharmaceuticals two commercial drugs led to better than expected financial results last quarter.
Benzinga  Jun 23  Comment 
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained more than 8 percent in after-hours trading Tuesday to $13.96 after the company posted positive results from a schizophrenia relapse prevention study of its Fanapt drug. The company will seek to...
FiercePharma  Jun 12  Comment 
The FDA has already admitted that it made a mistake with its initial approval letter for Vanda Pharmaceuticals' sleep disorder drug early last year, a consumer advocacy group says. And now, that group is demanding the agency do a better job fixing...

You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki